INKE

Castellbisbal, Spain Founded: 1980 • Age: 46 yrs Acquired By Keensight Capital
Manufacturer of active pharmaceutical ingredients and intermediates

About INKE

INKE is a Healthcare company based in Castellbisbal (Spain) founded in 1980, and was acquired by Keensight Capital in April 2023. Manufacturer of active pharmaceutical ingredients and intermediates. Its chief executive, as recorded, is Antonio Pages. INKE offers products and services including Respiratory APIs, Micronization Services, and CMO Services. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and API Production. Its legal entity is INKE S.A.

Company details

INKE was founded in 1980 as a wholly-owned subsidiary of Neuraxpharm and is based in Castellbisbal, Spain. Active pharmaceutical ingredients and intermediates are produced by the company, with a focus on respiratory and central nervous system products. These are used in treatments for conditions including asthma, COPD, schizophrenia, hypertension, insomnia, epilepsy, and allergies. Operations center on pharmaceutical manufacturing within the healthcare sector.

  • Headquarters Castellbisbal, Spain
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website inke.es
  • Social LinkedIn
  • Acquired by Keensight Capital (Apr 2023)
  • Legal Name Inke S.A.
Key Metrics

Products & Services of INKE

INKE offers a comprehensive portfolio of products and services, including Respiratory APIs, Micronization Services, and CMO Services.

Respiratory APIs
Active Pharmaceutical Ingredients

Develops ingredients for inhalation therapies to treat respiratory conditions effectively.

Micronization Services
Manufacturing Processes

Provides particle size reduction for pharmaceutical applications and quality assurance.

CMO Services
Contract Manufacturing

Offers custom manufacturing of APIs with advanced synthesis and global support.

Investors in INKE

INKE has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Keensight Capital.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Keensight Capital is recognized as a European Growth Buyout investor.
keensightcapital.comParis, France
Premium access

Investor details for INKE

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of INKE

15 people are tracked at INKE (10 in leadership, 5 in team).

NameRoleGroup
Antonio Pages
CEOLeadership
Arnau Novell
Operations Director (interim)Leadership
Miquel Bachs Taberner
CEOLeadership
Francesc Matas
Chief Information Officer (cio)Leadership
Jakob Rydberg
Chief Financial OfficerLeadership
Ferran Font
Head Of Analysis - Quality ControlLeadership
Laura Sánchez Salguero
R&d Director (cso)Leadership
Carlos Royo Escriche
Human Resources DirectorLeadership
Joan M. Botana Nuñez
Head Of Quality Assurance-gmpLeadership
Víctor Bertran Salmerón
HR Business PartnerLeadership
Jorge Llorens Noguera
Business Development Manager LatamTeam
Sergio Rodríguez Ropero
API Synthesis Team LeaderTeam
Paula Menu Mejia
Regulatory Affairs SpecialistTeam
Enric Capdevila Urbaneja
Senior API Synthesis Project LeaderTeam
Marc L.
Process ChemistTeam
Premium access

Complete people profiles for INKE

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of INKE

2 dated milestones of INKE across 43 years, from founding to its latest funding, stage changes and deals.

  1. Founded INKE is founded.
  2. Exit Acquired by Keensight Capital.

Web traffic of INKE

The website of INKE (inke.es) receives about 1.4K visits a month.

  • Monthly visits
    1.4K

    ▼ 74.6% vs previous month

Similar websites

Websites whose visitors overlap most with INKE. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
google.com
100%
85.8B#1View details
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Inke

Premium access

Complete news archive for INKE

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about INKE

INKE was founded in 1980.

INKE is headquartered in Castellbisbal, Spain. It is registered at Castellbisbal, Cataluna, Spain.

Antonio Pages is the CEO of INKE, as recorded in our data.

INKE was founded in 1980 as a wholly-owned subsidiary of Neuraxpharm and is based in Castellbisbal, Spain. Active pharmaceutical ingredients and intermediates are produced by the company, with a focus on respiratory and central nervous system products. These are used in treatments for conditions including asthma, COPD, schizophrenia, hypertension, insomnia, epilepsy, and allergies. Operations center on pharmaceutical manufacturing within the healthcare sector.

INKE offers Respiratory APIs, Micronization Services, and CMO Services.

INKE has 1 investor. Key investors include Keensight Capital.

INKE operates through Inke S.A..

Yes. INKE was acquired by Keensight Capital in April 2023.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available